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Abstract
Summary Patient characteristics contributing to imminent risk
for fracture, defined as risk of near-term fracture within the
next 12 to 24 months, have not been well defined. In patients
without recent fracture, we identified factors predicting immi-
nent risk for vertebral/nonvertebral fracture, including falls,
age, comorbidities, and other potential fall risk factors.
Purpose Several factors contribute to long-term fracture risk
in patients with osteoporosis, including age, bone mineral
density, and fracture history. Some patients may be at immi-
nent risk for fracture, defined here as a risk of near-term frac-
ture within 12–24 months. Many patient characteristics con-
tributing to imminent risk for fracture have not been well
defined. This case-control study used US commercial and
Medicare supplemental insured data for women and men
without recent fracture to identify factors associated with im-
minent risk for fracture.
Methods Patients included were aged ≥50 with osteoporosis,
had a vertebral or nonvertebral fracture claim (index date;
fracture group) or no fracture claim (control group) from
January 1, 2006, to September 30, 2012, continuously en-
rolled and without fracture in the 24 months before index.
Potential risk factors during the period before fracture were
assessed.
Results Using data from 12 months before fracture, factors
significantly associated with imminent risk for fracture were
previous falls, older age, poorer health status, specific
comorbidities (psychosis, Alzheimer’s disease, central nervous
system disease), and other fall risk factors (wheelchair use, psy-
choactivemedication use,mobility impairment). Similar findings
were observed with data from 24 months before fracture.
Conclusions In patients with osteoporosis and no recent frac-
ture, falls, older age, poorer health status, comorbidities, and
other potential fall risk factors were predictive of imminent
risk for fracture. Identification of factors associated with im-
minent risk for vertebral/nonvertebral fracture may help iden-
tify and risk stratify those patients most in need of immediate
and appropriate treatment to decrease fracture risk.
Keywords Falls . Fractures . Osteoporosis . Risk factors .
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Introduction
Osteoporosis poses a significant and increasing health burden
for the aging population [1, 2]. Osteoporotic fractures are
common and associated with significant morbidity, mortality,
and healthcare resource use [1, 3, 4]. Nonetheless, osteoporo-
sis remains widely undertreated, even in patients with recent
fractures [5, 6].
Several factors contribute to long-term fracture risk in pa-
tients with osteoporosis, including advanced age, fracture his-
tory, recent falls, low bone mineral density (BMD), and cer-
tain comorbidities, such as rheumatoid arthritis and causes of
secondary osteoporosis [7, 8]. Risk can be quantified using
fracture risk assessment tools (e.g., FRAX® andQFracture®),
which estimate the 10-year risk of fracture [7, 9]. However,
risk may not be constant over a 10-year period and being able
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to quantify vertebral or nonvertebral fracture risk over a
shorter time period could assist clinicians in identifying and
targeting therapy in patients with osteoporosis.
Risk factors that increase imminent risk, i.e., risk for fracture
within the next 12 to 24 months, have not been well character-
ized. Studies suggest that after a recent fracture, the risk for a
subsequent fracture is highest within the next 12 to 24 months
[10–13]. Other risk factors that may not be captured in long-term
fracture risk assessment tools include specific comorbidities and
medications affecting blood pressure, cognitive function, and/or
patient awareness that may contribute to the risk for falls, thus
increasing the risk of fracture [14–18].
Using a large US commercial and Medicare supple-
mental claims data set, we undertook a case-control study
aimed at identifying risk factors associated with imminent
fracture in patients with osteoporosis who have not had a
recent fracture.
Methods
Study design and population
This was a case-control study conducted using adminis-
trative claims data for individuals with osteoporosis who
were commercially insured or who had Medicare supple-
mental insurance in the USA. The study objective was to
identify factors predictive of imminent risk for fragility
fracture, defined as a risk of near-term fracture within
the next 12 to 24 months in patients with osteoporosis
without a recent documented fracture (in the previous
24 months).
Data sources
Data were obtained from the Truven Health Analytics
®
All patient data used in this analysis were de-identified in
compliance with the Health Insurance Portability and
Accountability Act regulations; therefore, the study did not
require Institutional Review Board approval.
Patient eligibility
All patients included in the study had at least one primary or
secondary diagnosis for osteoporosis (International
Classification of Diseases, Ninth Revision, Clinical Modification
[ICD-9-CM] diagnosis 733.0x) on an inpatient claim or an
outpatient diagnosis associated with physician evaluation or
management between January 1, 2004, and December 31,
2012.
Patients in the fracture group had a qualified claim for a
fragility fracture between January 1, 2006, and September 30,
2012, and an osteoporosis diagnosis from January 1, 2004, to
90 days after the fracture diagnosis. Patients were identified as
having a fragility fracture at hip, vertebral, or nonhip/
nonvertebral sites (radius and ulna, humerus, tibia and fibula,
ankle, pelvis, and clavicle) based on the presence of a primary
or secondary diagnosis using ICD-9-CM diagnosis codes in-
dicative of closed or pathologic fracture or an inpatient or
outpatient claim that carried a diagnosis of fracture and a cor-
responding fracture treatment for the same fracture site. For
vertebral fracture, an outpatient physician evaluation and
management claim with vertebral fracture diagnosis on the
same claim also qualified for inclusion. Fracture claims ac-
companied by any indication of major trauma (transport acci-
dents or other causes that may imply traumatic fracture; ICD-
9-CM diagnosis codes E800–848, E881–884, E908–909,
E916–928) within 7 days before or after the fracture diagnosis
were disqualified. The date of the first qualified fracture claim
was set as the index date.
Patients in the control group had no claim for fracture be-
tween January 1, 2004, and December 31, 2012. An index
date was randomly assigned based on the date of first osteo-
porosis diagnosis and the distribution of index dates in the
fracture group.
Eligible patients were required to be at least 50 years of age
at the index date, to be continuously enrolled for ≥730 days
(24 months) before the index date (preindex period), and to
have no fractures in the preindex period. Patients in both
groups were excluded if any of the following conditions oc-
curred in the 24-month preindex period: Paget disease, osteo-
genesis imperfecta, hypercalcemia, malignant cancer (identi-
fied by either ICD-9-CM diagnosis codes or chemotherapy),
HIV, or preventative treatment (raloxifene) in patients with a
history of breast cancer.
Assessments
Fracture risk factors
More than 60 patient characteristics and potential risk factors
for fracture, identified based on a literature review and clinical
input, were assessed. These included demographic factors
(e.g., history of falls, age, sex, geographic region, insurance
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MarketScan Commercial Claims and Encounters (Commercial)
and the Medicare Supplemental and Coordination of Benefits
(Medicare) databases. The Market-Scan Commercial database
contains the inpatient, outpatient, and outpatient prescription drug
data of approximately 35 million employees and their dependents
covered under a variety of fee-for-service and managed care plans
annually. The MarketScan Medicare Supplemental and
Coordination of Benefits database contains the same healthcare
data for approximately 4 million retirees and/or their dependents
with employer-sponsored Medicare supplemental health
insurance.
plan type, the season that fracture occurred), comorbidities
(e.g., Deyo-Charlson Comorbidity Index [DCI; a measure of
general health] [19], central nervous system [CNS] disease,
psychoses, Alzheimer’s disease), concomitant medications
(e.g., number of unique medications used; use of narcotics,
antidepressants, or sedatives/sleep aids), and mobility/frailty
factors (e.g., wheelchair use, mobility impairment, home
healthcare, being in a nursing home). The full list of potential
risk factors is shown in Supplemental Table S1.
The fracture risk factor evaluation periods are shown in
Fig. 1. Unless specified, demographic variables were
measured on the study index date. General health status mea-
sures were examined based on a 24-month preindex period.
Clinical factors, concomitant medications, and other factors
were captured during the 12- and 24-month preindex periods.
Statistical analysis
Descriptive analysis was conducted, including baseline and
follow-up measures for all patients meeting the study criteria.
Counts and proportions were provided for categorical vari-
ables, and counts, means, and standard deviations were
Patient Inclusion: ≥1 diagnosis of osteoporosis 1/1/2004–12/31/2012
1/1/04 1/1/06 9/30/12 12/31/12
Index Date = Date of first fracture
Index Date Measures: Demographics
Exposure/Assessment Period Characteristics:
▪ Fracture risk factors measured during 12-month and 24-month 
exposure/assessment period
EXPOSURE/ASSESSMENT PERIOD (24 Months)
INCIDENT FRACTURE INDEX PERIOD
 Fracture Group Indentification
Control Group IdentificationFig. 1 Study periods
≥1 diagnosis for osteoporosis from 
1/1/2004 to 12/31/2012
1,324,571 
≥1 diagnosis for fracture from1/1/2004
to 90 days after the fracture  
diagnosis code
120,020
No diagnosis for fracture from 
1/1/2004 to 12/31/2012
962,261
Aged ≥50 years on index date
595,023
Aged ≥50 years on index date 
115,733
Continuous enrollment and pharmacy 
data for 730 days preindex
194,950
Continuous enrollment + pharmacy data 
730 days preindex + ≥90 days from index 
55,190
No fracture preindex period
48,617
No exclusion conditions from preindex to 
90 days postindex
32,094
No exclusion conditions from preindex to 
90 days postindex
131,092
FRACTURE GROUP CONTROL GROUP
Fig. 2 Patient counts at key
points in patient data set selection
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provided for continuous variables. Risk factors for fracture
were identified bymultivariate logistic regressionmodels with
a binary indicator of fracture as the outcome model and co-
variates that included potential risk factors measured during a
fixed period before the fracture date or assigned date for con-
trols. Odds ratio of fracture was estimated for each potential




Of the 1,324,571 patients with an osteoporosis diagnosis,
163,186 met all inclusion criteria. Of these, 32,094 had a
fracture and formed the fracture group and 131,092 did not
have a fracture diagnosis and formed the control (nonfracture)
group (Fig. 2). The study population consisted of 29,004
women and 3090men in the fracture group and 119,922wom-
en and 11,170 men in the control group (Table 1). The mean
age of patients in the control group was lower than the fracture
group. In the fracture group, fractures were primarily nonhip/
nonvertebral (41.6 %), followed by vertebral (33.1 %) and hip
(25.4 %).
Factors associated with imminent risk for fracture
The 12- and 24-month preindex predictors of imminent risk
for fracture are included in Table 2. Of the factors assessed,
falls were the greatest risk factor for imminent fracture within
the next 12 months (odds ratio, 6.67 [95 % CI, 6.03–7.37]).
Other significant risk factors included advancing age (each
additional decade after the age of 50), poorer health status
assessed by DCI score >0, specific comorbidities (e.g., CNS
disease, psychoses, Alzheimer’s disease), concomitant medi-
cations (e.g., antidepressants [selective serotonin reuptake in-
hibitors (SSRIs), non-SSRIs, tricyclics], anti-Parkinson med-
ication, tranquilizers, narcotics, sedatives/sleep aids, muscle
relaxants), as well as factors related to mobility/frailty (e.g.,
wheelchair use, nursing home, home healthcare, mobility im-
pairment). Similar predictors were observed for imminent risk
of fracture within the next 24 months, with the exception of
tricyclics (Table 2).
Overall, risk factors were similar regardless of index
fracture type (Supplemental Table S2), including falls, ad-
vancing age, and poorer health status. Although comorbid-
ities, concomitant medications, and factors related to
mobility/frailty also predicted risk for fracture across index
fracture type, there were some differences in the specific
diseases, medications, and mobility/fragility factors by in-
dex fracture type and time period. For instance, psychoses,
Alzheimer’s disease, and tricyclics, were not identified as
being predictive of fracturewithin the next 12 and/or 24months
for patients with a vertebral or nonhip/nonvertebral fracture but
were found to be predictive for hip fracture.
Discussion
Using a large claims database, this study identified factors
contributing to imminent risk for hip vertebral, or nonvertebral
fracture in patients with osteoporosis without recent fracture.
Factors consistently associated with imminent risk for fracture
included previous falls, advancing age, and poorer health sta-
tus. Additional fall risk factors, such as specific comorbidities
associatedwith impaired cognitive and physical function, con-
comitant medications, and factors related to mobility/frailty,
were predictive at specific fracture sites.
This study assessed patients with osteoporosis without a
recent fracture to identify clinical factors, other than recent
fracture, that may contribute to imminent risk for fracture
[20]; recent fracture is a recognized strong predictor of immi-
nent fracture risk [21, 22]. Not surprisingly, falls and risk
factors associated with falls were predictive of fracture in
our study. Previous studies assessing imminent fracture risk
Table 1 Demographic characteristics
Fracture group Control group
N = 32,094 N= 131,092
Sex, n (%)
Male 3090 (9.6) 11,170 (8.5)
Female 29,004 (90.4) 119,922 (91.5)
Mean (SD) age, years 75.2 (11.7) 66.4 (10.4)
US geographic region, n (%)
Northeast 4277 (13.3) 19,929 (15.2)
North central 11,312 (35.2) 35,462 (27.1)
South 9954 (31.0) 46,908 (35.8)
West 6484 (20.2) 28,382 (21.7)
Unknown 67 (0.2) 411 (0.3)
Health plan type, n (%)
Comprehensive 12,797 (39.9) 31,613 (24.1)
PPO 12,694 (39.6) 63,376 (48.3)
POS 1322 (4.1) 9101 (6.9)
HMO 4220 (13.1) 19,740 (15.1)
Other 382 (1.2) 3458 (2.6)
Unknown 679 (2.1) 3804 (2.9)




HMO health maintenance organization, POS point of service, PPO pre-
ferred provider organization
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and factors affecting fall risk have shown that advancing age,
falls, comorbidities, and certain medications increase the risk
of fracture [23–25]. Both the National Osteoporosis
Foundation and the World Health Organization have identi-
fied a history of falls as a major risk for fracture [2, 26].
Indeed, it has been reported that more than 90 % of hip frac-
tures occur following a fall [27]. In addition, the incidence of
falls increases with advancing age because of age-related
physical and mental changes [28]. A systematic review of
observational studies on risk factors for falling in
community-dwelling older people showed that certain health
conditions and impairments contributed independently to the
risk of falls [29]. Conditions such as stroke, dementia, depres-
sion, and Parkinson’s disease are more common in older
adults and may increase fall risk due to impact on cognition
and physical function [28–31]. Also, the medications used to
manage these conditions can increase fall risk through their
effect on cognitive and physical functioning [25, 28, 32]. For
example, psychoactive medications (e.g., antidepressants,
sedatives, antipsychotics), anti-Parkinson drugs, and adverse
treatment events associated with these medications, including
unsteadiness, impaired alertness, and dizziness, increase fall
risk [15, 25, 29]. Moreover, the risk of falling increases with
the number of risk factors [28].
Overall, the risk factors identified by our study for
imminent risk for fracture are consistent with prior studies
assessing fracture risk over longer time horizons [14–17,
33–36]. However, many of these risk factors are not
accounted for in the long-term fracture risk assessment
models commonly used in clinical practice. Indeed, it
has been suggested that the lack of fall risk assessment
with FRAX® may underestimate fracture probability,
Table 2 Risk factors predictive of imminent risk for fracture (OR> 1) at any fracture site
Predictor 12 months prefracture
OR (95 % CI)
P value 24 months prefracture
OR (95 % CI)
P value
Demographic and general health characteristics
History of falls 6.67 (6.03–7.37) <0.0001 4.43 (4.09–4.80) <0.0001
Every additional decade after age 50 years 2.00 (1.98–2.03) <0.0001 1.97 (1.94–2.00) <0.0001
Comorbidities
CNS disease 1.41 (1.30–1.52) <0.0001 1.34 (1.25–1.43) <0.0001
Psychoses 1.37 (1.26–1.48) <0.0001 1.34 (1.25–1.44) <0.0001
Alzheimer’s disease 1.35 (1.22–1.50) <0.0001 1.25 (1.14–1.37) <0.0001
General health status measures
DCIa
≥4 1.46 (1.35–1.59) <0.0001 1.49 (1.38–1.62) <0.0001
3 1.40 (1.31–1.50) <0.0001 1.42 (1.32–1.52) <0.0001
2 1.26 (1.19–1.32) <0.0001 1.29 (1.22–1.36) <0.0001
1 1.16 (1.12–1.20) <0.0001 1.17 (1.13–1.22) <0.0001
Concomitant medications
Narcotics 2.11 (2.05–2.18) <0.0001 1.85 (1.79–1.92) <0.0001
Antidepressants—SSRIs 1.47 (1.41–1.52) <0.0001 1.41 (1.36–1.46) <0.0001
Muscle relaxants 1.40 (1.34–1.47) <0.0001 1.29 (1.25–1.35) <0.0001
Tranquilizers 1.29 (1.18–1.40) <0.0001 1.24 (1.15–1.34) <0.0001
Antidepressants—other 1.27 (1.21–1.33) <0.0001 1.22 (1.16–1.27) <0.0001
Anti-Parkinson 1.24 (1.15–1.35) <0.0001 1.20 (1.11–1.29) <0.0001
Antidepressants—tricyclics 1.09 (1.02–1.17) 0.0119 – NS
Sedatives and sleep aids, excluding benzodiazepines 1.05 (1.00–1.11) 0.0376 1.08 (1.03–1.12) 0.0010
Mobility/frailty
Wheelchair use 1.79 (1.61–2.00) <0.0001 1.80 (1.64–1.97) <0.0001
Mobility impairment 1.46 (1.41–1.51) <0.0001 1.39 (1.34–1.43) <0.0001
Home healthcare 1.24 (1.16–1.34) <0.0001 1.20 (1.13–1.28) <0.0001
Nursing home 1.19 (1.12–1.28) <0.0001 1.19 (1.13–1.26) <0.0001
Risk factors with OR>1 and significant (P< 0.05) included on table
CNS central nervous system, DCI Deyo-Charlson Comorbidity Index, NS nonsignificant, OR odds ratio, SSRI selective serotonin reuptake inhibitor
a Reference group: 0
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particularly in individuals with a history of falls, and in-
clusion could improve existing fracture prediction algo-
rithms [37, 38].
Since older people commonly have multiple risk factors,
including several comorbidities, and use multiple medica-
tions, knowledge about factors that increase risk may help
guide identification, and appropriate treatment, of patients at
imminent risk for fracture. Identification and management of
these patients are important because of the increased probabil-
ity of fracture and the associated morbidity, mortality, and cost
of fracture [1, 3–5, 39, 40]. Indeed, fractures are associated
with decline in functional status and health-related quality of
life [39, 41], lead to the development of comorbidities [2, 42],
and increase the risk of death by 25 % [3].
Management could include therapy to increase BMD and
interventions to increase bone strength, in addition to inter-
ventions to reduce falls. Although fall prevention strategies
and interventions to decrease and/or protect from falls could
be beneficial in reducing fracture, these options have had lim-
ited success and clinical studies have not consistently shown
reductions in the risk of falling [43, 44]. Other management
options may be required to strengthen bone and thus reduce
the likelihood of fracture if a fall occurs.
Strengths of this study include the large study population
over a time period of 2004 to 2012, with patients from across
the USA and various types of health plans. This study had
several limitations, including the potential for underreporting
of falls and fractures; only falls resulting in medical events,
procedures, and treatment were coded and included, and this
may not be a reliable measure of frequency. We could not
positively identify fragility fractures from medical claims
based on ICD-9-CM diagnosis codes; therefore, we required
closed or pathologic fracture in a specific treatment setting
and/or accompanied by physician evaluation and management
code, and E-codes to rule out fracture due to trauma. As a
result, imminent risk may be underestimated in this study.
Parental fracture history and BMD data, which are known risk
factors for fractures, were unavailable from administrative
claims data, limiting the number of risk factors examined. In
addition, all comorbidities may not be captured by claims cod-
ing ormay bemiscoded. Owing to the smaller sample ofmales
included in this study, analysis by sex was not undertaken, and
thus sex differences could not be assessed. Finally, this popu-
lation of patients who were either commercially insured or
who had Medicare supplemental health insurance may not
be representative of other insured or uninsured patient groups.
In conclusion, in men and women with osteoporosis and no
recent fracture, multiple factors were associated with imminent
risk for fracture, including older age, falls, comorbidities affect-
ing cognitive or physical function, and other potential fall risk
factors. Identification of factors putting patients at imminent risk
for fracture may help risk stratify those patients most at need of
immediate and appropriate treatment to decrease fracture risk.
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